O00255 (MEN1_HUMAN) Homo sapiens (Human)

Menin UniProtKBInterProSTRINGInteractive Modelling

610 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3)

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human menin in complex with MLL peptide
4gq6
 Heteromer
Q03164; 		2-588
3×SO4; 2×1PE;
Assess
Human menin in complex with H3K79Me2 nucleosome
8gpn
 Heteromer
P02281; P06897; P62799; P84233; 		2-587
Assess
Crystal structure of human menin in complex with MLL1 and LEDGF
3u88
 Heteromer
O75475; Q03164; 		2-583
1×CHD; 4×GGB; 1×0BR; 4×GLV; 4×SO4;
Assess
Crystal structure of human menin in complex with JunD
3u86
 Heteromer
P17535; 		2-581
Assess
Crystal structure of human menin in complex with MLL1
3u85
 Heteromer
Q03164; 		2-581
Assess
Crystal structure of menin in complex with DS-1594b
8ig0
homo-2-mer2-584
2×7IX; 2×UNX; 2×DMS;
Assess
Crystal structure of human menin in complex with a high-affinity macrocyclic peptidomimetics
4i80
homo-2-mer2-581
Assess
Inhibition of Human Menin by SNDX-5613
8e90
homo-2-mer2-457
2×OQ4; 4×EDO; 1×MES;
Assess
Inhibition of Human Menin by SNDX-5613
7uj4
homo-2-mer2-457
2×OQ4; 4×MG;
Assess
Crystal Structure of Human Menin
3u84
monomer2-608
Assess
Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leu…
4gpq
monomer2-589
2×PEG; 1×PG4; 1×EPE;
Assess
Menin in complex with MI-352
5db0
monomer2-589
3×PG4; 4×SO4; 4×DMS; 1×58P; 1×6E6;
Assess
Menin in complex with MI-389
5db2
monomer2-589
1×58R; 3×DMS; 1×PG4; 5×SO4; 1×PEG;
Assess
Menin in complex with MI-503
4x5y
monomer2-589
1×3XW; 3×DMS; 1×PG4; 3×SO4; 1×EDO; 1×EPE;
Assess
Menin in complex with MI-326
5dd9
monomer2-589
1×59K; 5×DMS; 2×PG4; 1×PGE; 4×SO4;
Assess
Menin in complex with MI-3454
6o5i
monomer2-588
1×LMY; 4×DMS; 3×SO4; 1×PG4;
Assess
Human menin with bound inhibitor MI-2-2
4gq4
monomer2-588
1×0RT; 5×UNX; 1×EPE; 4×SO4; 2×PE4; 1×DMS;
Assess
Human menin with bound inhibitor MIV-3S
4og4
monomer2-588
1×SO4; 1×2VK; 1×PG4; 1×PGE; 2×PEG; 4×DMS; 1×TBF;
Assess
Human menin with bound inhibitor MIV-4
4og6
monomer2-588
1×SO4; 1×2S9; 1×PG4; 3×PEG; 4×DMS;
Assess
Menin in complex with peptide inhibitor 25
6opj
monomer2-588
4×DMS; 3×SO4; 1×PG4;
Assess
Human menin with bound inhibitor MIV-6R
4og8
monomer2-588
2×TBF; 1×2SF; 1×PG4; 3×SO4; 3×DMS; 1×PGA;
Assess
Human menin with bound inhibitor MI-2
4gq3
monomer2-588
1×0RO; 1×PEG; 5×UNX; 5×SO4;
Assess
Menin in complex with MI-2-3
5ddc
monomer2-588
1×59V; 4×DMS; 1×PGE; 1×PEG; 1×EPE;
Assess
Human menin with bound inhibitor MIV-5
4og5
monomer2-588
1×2S7; 2×SO4; 1×PG4; 1×PEG; 3×DMS; 1×TBF;
Assess
Menin in complex with MI-574
5db3
monomer2-588
3×DMS; 2×PG4; 4×SO4; 1×PEG; 1×58Q;
Assess
Menin in complex with MI-859
5dde
monomer2-588
2×5A0; 4×SO4; 4×DMS; 1×PG4; 1×EDO;
Assess
Menin in complex with MI-1481
6bxy
monomer2-588
1×EEV; 3×DMS; 2×PG4; 3×SO4; 1×EDO;
Assess
Menin in complex with MI-336
5db1
monomer2-588
1×58O; 3×DMS; 5×SO4; 3×PG4;
Assess
menin in complex with MI-136
4x5z
monomer2-588
4×SO4; 1×3XY; 1×PG4; 2×DMS; 1×EDO;
Assess
Menin in complex with MI-1482
6by8
monomer2-588
1×FNV; 4×DMS; 2×PG4; 2×SO4; 1×EDO;
Assess
Human menin with bound inhibitor MIV-7
4og7
monomer2-588
1×SO4; 1×2SE; 1×PGE; 2×PEG; 4×DMS;
Assess
menin in complex with MI-836
5ddd
monomer2-588
1×59X; 4×SO4; 4×DMS; 1×PG4; 1×PEG;
Assess
Menin in complex with MI-273
5ddf
monomer2-587
1×5A1; 4×DMS; 1×PG4; 1×PEG; 3×SO4;
Assess
Menin in complex with MI-333
5dda
monomer2-587
1×59M; 4×DMS; 2×PGE; 1×EDO; 5×SO4;
Assess
Menin in complex with MI-319
5ddb
monomer2-586
1×59Q; 5×DMS; 2×PG4; 1×PEG; 4×SO4;
Assess
Human menin with bound inhibitor MIV-3R
4og3
monomer2-586
1×SO4; 1×2S6; 1×PG4; 2×PEG; 4×DMS;
Assess
Inhibition of Human Menin by VTP-50469
6pkc
monomer2-583
1×OP4;
Assess
Crystal structure of Human Menin in complex with BD-08
7o9z
monomer1-582
1×V6N; 3×EDO; 2×GOL;
Assess
Crystal structure of Human Menin in complex with Fragment 21
7oa9
monomer1-582
1×V6K; 7×EDO; 1×GOL;
Assess
Crystal structure of Human Menin in apo form
7o9t
monomer1-582
2×EDO;
Assess
Crystal structure of Human Menin with fragment 16
7o9x
monomer1-582
1×V6Q; 2×GOL; 3×EDO;
Assess
Menin bound to inhibitor M-808
6wnh
monomer2-581
1×7MM; 5×7PR;
Assess
Menin bound to M-525
6b41
monomer2-581
1×CJV; 4×7PR;
Assess
Menin bound to M-1121
7m4t
monomer2-581
1×YQV; 5×7PR;
Assess
Menin bound to M-89
6e1a
monomer2-581
1×HL7; 5×7PR;
Assess
Human Menin in complex with AJ21
6s2k
monomer3-581
Assess
Menin in complex with MI-853
6bxh
monomer2-459
1×DMS; 1×SO4; 1×EE7;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3u84.1.Amonomer0.772-608
99.27
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 13u84.1.Amonomer0.772-613
99.27
Assess
Isoform 33u84.1.Amonomer0.782-572
99.22
Assess